Becton Dickinson Newswire

Comprehensive Real-Time News Feed for Becton Dickinson.

Results 1 - 20 of 220 in Becton Dickinson

  1. Syringes & Accessories Procurement Category Market Research Report from IBISWorld has Been UpdatedRead the original story w/Photo

    Saturday Dec 20 | PRWeb

    Stable demand for syringes, which are largely considered nondiscretionary, and rising prices of raw materials have contributed to steady price growth for syringes over the past three years. For these reasons and to help procurement professionals make better buying decisions faster, business intelligence firm IBISWorld has updated a report on the procurement of Syringes & Accessories in its growing collection of procurement category market research reports.

    Comment?

  2. Becton, Dickinson and Company and Novo Nordisk Dominate the Global Pen...Read the original story w/Photo

    Saturday Dec 20 | PRWeb

    The Insulin pen needles market is highly competitive with a large number of players, including both big and small players, operating in this market. Key Players - B. Braun Melsungen AG , HTL-Strefa S.A. , Terumo Corporation , Artsana S.p.a , Owen Mumford Ltd , Allison Medical, Inc. The global Insulin pen needles market is dominated by three major players, namely, Becton, Dickinson and Company , Novo Nordisk , and Ypsomed Holding AG .

    Comment?

  3. Practitioner Guilty of Inequitable Conduct: Considerations and...Read the original story w/Photo

    Wednesday Dec 10 | jdsupra.com

    In its 2011 Therasense, Inc. v. Becton Dickinson & Co. decision, the Court of Appeals for the Federal Circuit set forth a more forgiving "but-for" causality standard for determining whether a patent is unenforceable due to inequitable conduct.

    Comment?

  4. Practitioner Guilty of Inequitable Conduct: Considerations and...Read the original story w/Photo

    Thursday Dec 11 | JD Supra

    In its 2011 Therasense, Inc. v. Becton Dickinson & Co. decision, the Court of Appeals for the Federal Circuit set forth a more forgiving "but-for" causality standard for determining whether a patent is unenforceable due to inequitable conduct.

    Comment?

  5. Eleanor Steiner diesRead the original story w/Photo

    Wednesday Dec 10 | NorthJersey.com

    ... of five sisters and had a younger brother. She lived most of her life in North Arlington and retired from Becton Dickinson & Company. Family and friends will be received Saturday, Dec. 13, from 11:30 a.m.-12:30 p.m., at the Ippolito-Stellato Funeral ...

    Comment?

  6. 1% Portfolio: Has The Dollar Index Topped?Read the original story w/Photo

    Wednesday Dec 10 | Seeking Alpha

    We bought 3 more bellwether stocks for the long term. , & will provide us with capital growth and dividend payments for months and years to come.

    Comment?

  7. Time To Add Growth To Your Dividend Growth PortfolioRead the original story w/Photo

    Tuesday Dec 9 | Seeking Alpha

    ... Owning these retained earrings is a less certain but very important part of a market income strategy. Think Becton Dickinson (NYSE: BDX ), Disney (NYSE: DIS ) or Apple (NASDAQ: AAPL ). With very little price growth Equity B will be treated by the ...

    Comment?

  8. Just Published: "Global Sexually Transmitted Disease (STD) Testing Market 2014-2018"Read the original story

    Tuesday Dec 9 | PR-inside.com

    ... of the key vendors operating in this market. Key Regions * Americas * APAC * EMEA Key Vendors * Alere * Becton Dickinson and Company * bioMerieux * F. Hoffmann-La Roche Other Prominent Vendors * Abbott * Bio-Rad * Cepheid * DiaSorin * Erba ...

    Comment?

  9. BD to Present Total Hospital Pharmacy Solutions at the 2014 American...Read the original story

    Monday Dec 8 | Freshnews

    BD Medical, a segment of BD , a leading global medical technology company, is presenting its comprehensive solutions for the hospital pharmacy during the 49th American Society of Health-System Pharmacists Midyear Clinical Meeting taking place December 7-11, 2014 at the Anaheim Convention Center in Orange County, California. Building on BD's legacy and commitment to supporting safety and efficiency in healthcare, the solutions on display at Booth #1101 demonstrate a cohesive approach to reducing the possibility of human error, protecting healthcare workers from occupational hazards, standardizing practice, streamlining workflow and increasing efficiency from medication preparation to delivery.

    Comment?

  10. Becton, Dickinson and Company And CareFusion Corporation Announce...Read the original story

    Sunday Dec 7 | BioSpace

    CareFusion stockholder approval is a condition to the merger. In addition to CareFusion stockholder approval, the proposed acquisition remains subject to certain other conditions and approvals, including approval of the proposed acquisition by the European Commission under the European Union Merger Regulation.

    Comment?

  11. Global PCR Technologies Market Size, Share, Growth, Analysis, Trends & Forecast to 2020Read the original story

    Monday Dec 8 | PRWeb

    Marketresearchreports.biz has announced the addition of the "Global PCR Technologies Market - Trends & Forecast to 2020" report to their offering. This 250-page report on the global Polymerase Chain Reaction market states that the global PCR market will demonstrate a CAGR of over 9% during 2014 to 2020 and reach a market size of US$14 billion by end of 2020.

    Comment?

  12. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Friday Dec 5 | Business Wire

    The report is available at 'www.fitchratings.com'. Additional information is ... )--Fitch Ratings has affirmed the class A-1a notes and class A-1b notes of ALM VIII, Ltd./LLC .

    Comment?

  13. Profit For The Buyer, Profit For You: Becton, Dickinson To Acquire CareFusionRead the original story w/Photo

    Sunday Dec 7 | Seeking Alpha

    The spread is very small and the M&A will be long so in this case we prefer to buy the buyer group. Becton, Dickinson & Co.

    Comment?

  14. Aethon and BD Announce Collaboration to Develop Integrated Medication Management SolutionRead the original story

    Friday Dec 5 | Customer Interaction Solutions

    Aethon, Inc. and BD , a leading global medical technology company, announced today a collaboration to integrate their solutions to provide hospital pharmacies with a comprehensive intravenous medication preparation and delivery tracking solution. With a pilot project already underway, the integrated solution will combine BD's leading-edge BD Cato IV Workflow product with Aethon's MedEx medication delivery tracking system.

    Comment?

  15. How to Reduce Your Tax Bill in Five MovesRead the original story w/Photo

    Friday Dec 5 | Money Morning

    Biotech Insider Alert tracks the most crucial milestones in a new drug or medical technology's journey to the marketplace - and shows you how to invest for maximum gains. This fast-paced technical trading service shows regular investors how to profit just like pros - taking big, reliable gains quickly, over and over, with minimal risk.

    Comment?

  16. Busy December sets up 2015Read the original story

    Friday Dec 5 | Reuters

    Medical equipment supplier Becton Dickinson pushed the first week of December into record territory on Thursday, with a US$6.2bn five-part transaction to help pay for its US$12.2bn acquisition of CareFusion. The deal was the third jumbo offering to come to market in four days, following on from Medtronic's US$17bn acquisition financing - the biggest deal this year - and a US$6bn trade by Amazon.

    Comment?

  17. Europe injectable drug delivery market: $12.4 billion industry by 2017Read the original story w/Photo

    Friday Dec 5 | PR-inside.com

    ... and favorable reimbursement policies for injectable devices. The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), ...

    Comment?

  18. Becton, Dickinson and Company To Offer Senior Unsecured NotesRead the original story

    Wednesday Dec 3 | BioSpace

    The interest rate, the maturity dates and other key terms of the offering are to be determined at the time of pricing. BD intends to use the net proceeds from the offering, together with borrowings under its commercial paper program, borrowings under a new term loan facility, and cash on hand, to finance the acquisition of CareFusion Corporation and to pay related fees and expenses.

    Comment?

  19. BD announces offeringRead the original story w/Photo

    Thursday Dec 4 | NorthJersey.com

    Franklin Lakes-based medical technology company Becton Dickinson & Co. said Thursday it plans to offer senior unsecured notes to help finance BD's $12.2 billion acquisition of CareFusion Corp., the biggest purchase in company, that was announced in October The notes will be filed under a shelf-registration statement with the Securities and Exchange Commission.

    Comment?

  20. Microfluidics Market worth $3.5 Billion by 2018Read the original story

    Thursday Dec 4 | Electronics Industry Market Reports

    ... adoption of microfluidics in IVD by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.). The various advantages offered by microfluidics are reduced ...

    Comment?